Overview Fundamentals API Earnings EOD API Sample Code Pricing

Arcutis Biotherapeutics Inc (ARQT NASDAQ) stock market data APIs

$9.79 0.04(0.4%) as of July 19, 2024
Price chart is built with Anychart

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Arcutis Biotherapeutics Inc Financial Data Overview

9.75
9.79
-
9.92
9.62
1.76-13.17
1 129 M
116 M
106 M
-0.32
1.178
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ARQT',
Type: 'Common Stock',
Name: 'Arcutis Biotherapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00QN8K4M4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1787306',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-01-31',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Arcutis Biotherapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 106 M
  • EBITDA -194 942 000
  • Earnings Per Share -2.79
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Arcutis Biotherapeutics Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.73

Get Arcutis Biotherapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com